Last price paid | 1.34 | |
Change | +1.52% [ +0.02 ] | |
Last traded volume | n.a. Unit | |
Cumulative volume | n.a. Unit | |
Date/time | 05.07.2024 17:20 |
Fixing | n.a. |
Settlement date | 05.02.2024 |
Last trading | n.a. |
Final fixing | n.a. |
Currency redemption | CHF |
Perf. since issue | +198.89% |
Year to date (YTD) | n.a. |
1 month | +14.53% |
3 months | +55.81% |
1 year | n.a. |
3 years | n.a. |
Issue price | 0.45 |
Underlying price on issue | 793.90 |
Premium | 0.01% |
Premium p.a. | n.a. |
Leverage | n.a. |
Implied volatility | n.a. |
ISIN | CH1305135530 |
Symbol | INO1TZ |
Security | 130513553 |
Exchange | SIX Structured Products |
Currency | CHF |
Expiry | n.a. |
Underlying | Novo Nordisk -B-, DK0062498333 |
Underlying ISIN | DK0062498333 |
Funding level | 723.529700 |
Stop-loss level | 751.850000 |
Distance to stop-loss level | 22.81% |
Long/Short type | Long |
Subscription ratio | 25.00 |
Issuer | Zürcher Kantonalbank |
Exercise type | n.a. |
Minimum execution | n.a. |
Value day | 01.02.2024 |
Premium | 0.77% |
Premium p.a. | n.a. |
Leverage | 3.77 |
Moneyness | in-the-money |
Leverage | n.a. |
Delta | n.a. |
Intrinsic value | 250.470300 |
Break-even | n.a. |
SSPA value at risk | n.a. |
SSPA risk rating | n.a. |
SSPA derivative category | Leverage |
SSPA code | Mini future (2210) |
Name | Price |
---|---|
Partners Group Ho... | 1'217.00 |
Lonza Group | 502.20 |
Swiss Life Hldg | 659.40 |
ROCHE GS | 243.30 |
SWISSCOM N | 511.50 |
Name | Price |
---|---|
SONOVA HLDG N | 275.80 |
ABB Ltd | 49.73 |
LOGITECH INT. | 84.60 |
Givaudan | 4'257.00 |
KUEHNE & NAGEL | 264.10 |